UCB Bulgaria is integral part of UCB group of companies: global biopharmaceutical company with 90 years of history and focused on creating value for people living with
severe diseases in immunology and neurology now and into the future. We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives, while creating value for society. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients
UCB’s business is strong and ranked 3rd among top Belgium companies by market capitalization as on Jan 1st, 2021##. Total revenue grew to €5.3 billion in 2020. We are
more than 7,600 people in all four corners of the globe, inspired by patients and driven by science.